1 as described in this issue by Neil Yeates, 2 suggests that the present drug regulation system needs improvement. The most substantive change in the new framework is that Health Canada will take a more active role after a drug reaches the market. In addition, Health Canada's decision-making will become more evidence-based, accountable, efficient and transparent, and there will be an increased ...